Where I see patients (1)
My reviews
Selected research
-
LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia.
Haematologica
-
FLT3 targeting in the modern era: from clonal selection to combination therapies.
International journal of hematology
-
Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML.
Cell reports. Medicine
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421
4.9